The effects of the combination treatment on tumour volume are consistent with those from the Rux treated mice, confirming that overall, a combination STAT3 and Ref‐1 inhibitors reduced tumour growth in the presence of the appropriate microenvironment. This evidence concerns the gene STAT3 and neoplasm.